An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Treatment Acquiring Popularity Online
The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these accounts directly for source information, while also obtaining discount codes.
Active Trade on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors market the drug there before redirecting customers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Voice Concerns
However, doctors and pharmacists have cautions that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals administering products of uncertain source.
Some experts said the demand for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the British medical regulations.
Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach medicines, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Service Reaction and Content Removal
According to TikTok, the service has removed problematic content and banned associated hashtags and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Research also found groups with up to 9,000 members marketing retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of members, filled with images of slimming results, glowing reviews and step-by-step guides for preparing or administering at home.
After minutes of entering one community, a seller posted WhatsApp details, where most purchases occur. The vendor provided an guidebook and guaranteed delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.
Item Information and Pricing
Within these communities, messages show black plastic packages with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Service Oversight and Security Actions
A representative for the messaging service said it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they can’t verify. Although the science behind this drug is sound, these online products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her staff has already encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject patients to possibly significant health risks”.
